Public-registry site landscape for NCT07700238, a Primary Immune Thrombocytopenia study sponsored by Amgen. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07700238 (registry record) |
| Sponsor | Amgen |
| Condition(s) | Primary Immune Thrombocytopenia |
| Phase | PHASE3 |
| Listed sites | 0 |
Eichor generates a preliminary site-risk snapshot for NCT07700238 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →